Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for the prevention of venous thromboembolism in patients with spine metastasis
TCTR20191022003Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in venous thromboembolism (VTE), cancer, sponsored by Faculty of Medicine, Chiang Mai University. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)cancer
Beyond the preview
Go deeper on TCTR20191022003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191022003.